00719 山東新華製藥股份
按盘价 
5.820 +0.120 (+2.105%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 资产回报率 (%) | 6.000% | 5.271% | 4.833% | 4.802% | 4.843% |
| 股东资金回报率 (%) | 11.441% | 10.826% | 10.417% | 10.491% | 10.591% |
| 资本运用回报率 (%) | 8.560% | 8.050% | 7.216% | 6.894% | 7.593% |
边际利润分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | -- | -- | -- | -- | -- |
| 未计利息、税项、折旧及摊销前利润率 (%) | 13.182% | 13.268% | 13.968% | 14.722% | 13.859% |
| 税前边际利润率 (%) | 6.576% | 6.288% | 6.421% | 6.854% | 6.803% |
| 纯利率 (%) | 6.129% | 5.479% | 5.313% | 5.409% | 5.351% |
变现能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流动比率 (X) | 1.333 X | 1.094 X | 1.101 X | 1.128 X | 0.977 X |
| 速动比率 (X) | 0.805 X | 0.711 X | 0.690 X | 0.656 X | 0.522 X |
财务杠杆分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 总负债 / 总资产比率 (%) | 42.365% | 47.372% | 50.203% | 52.188% | 51.670% |
| 总债项 / 总资产比率 (%) | 16.397% | 11.900% | 21.960% | 14.423% | 22.077% |
| 净债项 / 总资产比率 (%) | 5.314% | -2.120% | 11.804% | 2.358% | 11.349% |
| 总债项 / 股东资金比率 (%) | 29.841% | 23.835% | 46.428% | 31.734% | 47.857% |
| 长期债项 / 股东资金比率 (%) | 17.592% | 13.290% | 27.408% | 14.409% | 19.893% |
| 净债项 / 股东资金比率 (%) | 9.672% | -4.247% | 24.956% | 5.188% | 24.601% |
| 净现金 / (债项) ($) | (4.40亿) | 1.75亿 | (8.65亿) | (1.67亿) | (7.30亿) |
| 每股净现金 / (债项) ($) | (0.653) | 0.262 | (1.379) | (0.269) | (1.175) |
| 总债项 / 资本运用比率 (%) | 23.425% | 19.260% | 33.335% | 21.711% | 35.967% |
| 利息盈利率 (X) | 13.945 X | 10.491 X | 8.932 X | 7.888 X | 7.895 X |
营运效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存货周转率日数 (日) | -- | -- | -- | -- | -- |
| 应收贸易帐周转率日数 (日) | 33.505日 | 35.968日 | 30.031日 | 20.944日 | 25.778日 |
| 应付贸易帐周转率日数 (日) | 51.093日 | 52.453日 | 50.334日 | 46.841日 | 55.033日 |
| 备注： | 实时报价更新时间为29/11/2024 12:53 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | RMB 265,404 |
| 增长率 | -1.632% |
| 每股盈利/(亏损) | RMB 0.390 |
| 每股账面资产净值 (¥) | RMB 6.967 |